PK Linearity and Steady State PK of CHF 6532 in Healthy Subjects

Summary

The purpose of this clinical pharmacology study is to evaluate the CHF 6532 linearity after single oral administrations of four doses of a tablet formulation and to evaluate the pharmacokinetic (PK) at steady state following the repeated open label b.i.d. administration at one dose.

Timeline

Start

2019-05-10

Primary completion

2019-11-22

Completion

2019-11-22

Drugs

Indications